Clinical trial
Safety and Tolerability of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Renal…
NCT00150020 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00150020 |
|---|---|
| Title | Safety and Tolerability of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Patients With GI Intolerance |
| Official title | Safety and Tolerability of Enteric-Coated Mycophenolate Sodium in Renal Transplant Patients With GI Intolerance |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Renal Transplantation |
| Intervention type | Drug |
| Interventions | Enteric-coated mycophenolate sodium (EC-MPS) |
| Enrollment | 728 |
| Start date | Oct 1, 2004 |
| Primary completion | Feb 1, 2006 |
| First posted | Sep 8, 2005 |
| Last update posted | Jan 24, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: